Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 11/20 | 0.48 |
| ▸ | CPS1 | P31327 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GHSR | Q92847 | 2/20 | 0.39 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31416218 | 1.00 | HRH4 (0.48) | HRH4CPS1CCR1HRH1HRH3 | |
| SCHEMBL31416309 | 0.89 | HRH4 (0.61) | HRH4HRH1HRH3GHSRBAZ2B | |
| SCHEMBL31416313 | 0.89 | HRH4 (0.61) | HRH4HRH1HRH3GHSRBAZ2B | |
| SCHEMBL31416196 | 0.84 | HRH4 (0.62) | HRH4HRH1HRH3MEN1KMT2A | |
| SCHEMBL31416197 | 0.81 | HRH4 (0.65) | HRH4HRH1HRH3GHSRHTT | |
| SCHEMBL31416177 | 0.81 | HRH4 (0.65) | HRH4HRH1HRH3GHSRHTT | |
| SCHEMBL31416375 | 0.80 | CPS1 (0.40) | CPS1CCR1GHSRHTTL3MBTL1 | |
| SCHEMBL31416249 | 0.80 | CPS1 (0.40) | CPS1CCR1GHSRHTTL3MBTL1 | |
| SCHEMBL31416392 | 0.76 | HRH4 (0.57) | HRH4HRH1HRH3MEN1KMT2A | |
| SCHEMBL31416416 | 0.76 | HRH4 (0.57) | HRH4HRH1HRH3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747234-A1 | KV1.3 POTASSIUM CHANNEL ANTAGONISTS | Muna Therapeutics ApS (DK) | 2026-05-27 | — | — | EP | disclosed |
| WO-2025017103-A1 | KV1.3 POTASSIUM CHANNEL ANTAGONISTS | MUNA THERAPEUTICS APS (DK) | 2025-01-23 | — | — | WO | disclosed |